Roche obesity drug shows 22.5% weight loss as it seeks to catch up with Lilly, Novo
Roche obesity drug shows 22.5% weight loss in Phase-II trialRoche focuses on catching Lilly in $150 billion obesity…
Roche boosts US presence with new $700 million North Carolina facility
May 12 (Reuters) – Roche Group (ROG.S), opens new tab said on Monday that it plans to invest…
Ethos rejects Novartis CEO, management pay as excessive
ZURICH, Feb 24 (Reuters) – Proxy advisory firm Ethos on Tuesday urged shareholders of Novartis (NOVN.S), opens new…